Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1426 - 1426 of 1426

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 601 - 602 of 602

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 110 of 110

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 27 of 27

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1751 - 1775 of 2138

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Status	Project Number
Ledipasvir / Sofosbuvir	cdr_SR0395_Harvoni.pdf cdr_complete_SR0395_Harvoni_Mar_20-15.pdf SR0395_Harvoni_CL_Report_e.pdf SR0395_Harvoni_PE_Report_e.pdf SR0395 Harvoni_PI_Submissions_e.pdf	Sep 15, 2014	Reimbursement Review	Complete	SR0395-000
Pirfenidone	cdr_SR0393_Esbriet.pdf cdr_compelte_SR0393_Esbriet_Apr-17-15.pdf SR0393_Esbriet_CL_Report_resub.pdf SR0393_Esbriet_PE_Report_resub.pdf	Aug 29, 2014	Reimbursement Review	Complete	SR0393-000
Pomalyst for Multiple Myeloma - Details	pcodr_profund_pomalidomide_pomalyst_mm.pdf pcodr-pomalyst-mm-fn-rec.pdf pcodr-pomalyst-mm-fn-cgr.pdf pcodr-pomalyst-mm-in-rec.pdf pcodr-pomalyst-mm-pag-fdk.pdf pcodr-pomalyst-mm-fdk-celgene.pdf pcodr-pomalyst-mm-fdk-myelcan.pdf pcodr-pomalyst-mm-coi-myelcan.pdf	Aug 18, 2014	Reimbursement Review	Complete	PC0036-000
Eslicarbazepine acetate	cdr_SR0391_Aptiom.pdf cdr_complete_SR0391_Aptiom_Apr-20-15.pdf SR0391_Aptiom_CL_Report.pdf SR0391_Aptiom_PE_Report.pdf SR0391 Aptiom_PI_Submissions_e.pdf	Aug 15, 2014	Reimbursement Review	Complete	SR0391-000
Taliglucerase alfa	cdr_SR0390_Elelyso.pdf SR0390_Elelyso_Oct-30-15.pdf SR0390_Elelyso_CL_Report.pdf SR0390_Elelyso_PE_Report.pdf	Aug 15, 2014	Reimbursement Review	Complete	SR0390-000
Rifaximin	cdr_SR0388_Zaxine.pdf cdr_complete_SR0388_Zaxine-Apr-20-15.pdf SR0388_Zaxine_CL_Report_e.pdf SR0388_Zaxine_PE_Report_e.pdf SR0388 Zaxine_PI_Submissions_e.pdf	Aug 5, 2014	Reimbursement Review	Complete	SR0388-000
Elosulfase alfa	cdr_SR0389_Vimizim.pdf SR0389_complete_Vimizim_Mar-27-15.pdf SR0389_Vimizim_CL_Report_e.pdf SR0389_Vimizim_PE_Report_e.pdf SR0389 Vimizim_PI_Submissions_e.pdf	Aug 5, 2014	Reimbursement Review	Complete	SR0389-000
Dolutegravir / abacavir / lamivudine	cdr_SR0387_Triumeq.pdf cdr_complete_SR0387_Triumeq_Apr-21-15.pdf SR0387_Triumeq_FDC_Review_Report_e.pdf	Jul 31, 2014	Reimbursement Review	Complete	SR0387-000
Giotrif for Advanced Non Small Cell Lung Cancer - Details	pcodr-provfund_giotrif-nsclc.pdf pcodr-giotrif-nsclc-fn-rec.pdf pcodr-giotrif-nsclc-fn-cgr.pdf pcodr-giotrif-nsclc-fn-egr.pdf pcodr-giotrif-nsclc-in-rec.pdf pcodr-giotrif-nsclc-pagfdk.pdf pcodr-giotrif-nsclc-infdk-bicl.pdf pcodr-giotrif-nsclc-ptfdbk-lcc.pdf pcodr-giotrif-nsclc-coi-lcc.pdf	Jul 25, 2014	Reimbursement Review	Complete	PC0032-000
Lomitapide	cdr_SR0386_Juxtapid.pdf cdr_complete_SR0386_Juxtapid-Apr-21_15.pdf SR0386_Juxtapid_CL_Report_e.pdf SR0386_Juxtapid_PE_Report_e.pdf media:document:1613e67a-34b5-425b-91a2-3240102d189c	Jul 8, 2014	Reimbursement Review	Complete	SR0386-000
Certolizumab pegol	cdr_SR0385_Cimzia.pdf cdr_complete_SR0385_Cimzia-AS_Apr-21-15.pdf SR0385_Cimzia_AS_PI_Submissions.pdf SR0385_CimziaAS_CL_Report_e.pdf SR0385_CimziaAS_PE_Report_e.pdf	Jun 23, 2014	Reimbursement Review	Complete	SR0385-000
Infliximab	TS0001-PsO-Updated-Streamlined-Rec.pdf cdr_SE0384_Inflectra.pdf cdr_complete_SE0384_Inflectra_Dec-23-14.pdf SE0384_Inflectra_SEB_Report.pdf SE0384 Inflectra_PI_Submissions.pdf	Jun 17, 2014	Reimbursement Review	Complete	SE0384-000
Infliximab	cdr_SE0383_Remsima.pdf	May 30, 2014	Reimbursement Review	Withdrawn	SE0383-000
Ingenol mebutate	cdr_SF0382_Picato RfA.pdf cdr_complete_SF0382_Picato-RfA_Oct_29-14.pdf SF0382_PicatoRfA_CDEC_Briefing_Doc.pdf	May 26, 2014	Reimbursement Review	Complete	SF0382-000
Darunavir/cobicistat	cdr_SR0381_Prezcobix.pdf cdr_complete_ SR0381_Prezcobix_Mar_20-15.pdf SR0381_Prezcobix_CL_Report_e.pdf SR0381_Prezcobix_PE_Report_e.pdf media:document:3ceeb6a7-4e2b-4c15-ae53-9bec3bf123c4	May 22, 2014	Reimbursement Review	Complete	SR0381-000
Stivarga for Gastrointestinal Stromal Tumours - Details	pcodr_profund_regorafenib_stivarga_gist.pdf pcodr-stivarga-gist-fn-rec.pdf pcodr-stivarga-gist-fn-cgr.pdf pcodr-stivarga-gist-fn-egr.pdf pcodr-stivarga-gist-in-rec.pdf pcodr-stivargagist-pagfdk.pdf pcodr-stivargagist-fdk-bayer.pdf pcodr-stivargagist-fdk-scfc.pdf pcodr-stivargagist-coi-scfc.pdf	May 20, 2014	Reimbursement Review	Complete	PC0034-000
Tofacitinib	cdr_SR0380_Xeljanz.pdf cdr_complete_SR0380_Xeljanz_Apr-21-15.pdf SR0380_Xeljanz_CL_Report.pdf SR0380_Xeljanz_PE_Report.pdf	May 5, 2014	Reimbursement Review	Complete	SR0380-000
Ivacaftor	cdr_SR0379_Kalydeco CF.pdf cdr_complete_SR0379_Kalydeco_Dec-23-14.pdf SR0379_KalydecoCF_CL_Report.pdf SR0379_KalydecoCF_PE_Report.pdf SR0379_Kalydeco_PI_Submissions_e.pdf	May 1, 2014	Reimbursement Review	Complete	SR0379-000
Darunavir / cobicistat	cdr_SR0378_Darunavir.pdf	Apr 4, 2014	Reimbursement Review	Withdrawn	SR0378-000
Eltrombopag	cdr_SR0377_Revolade.pdf cdr_complete_SR0377_Revolade_Mar-23-2015_e.pdf SR0377_RevoladeTCP_CL_Report.pdf SR0377_RevoladeTCP_PE_Report.pdf SR0377 Revolade TCP_PI_Submissions.pdf	Mar 31, 2014	Reimbursement Review	Complete	SR0377-000
Everolimus	cdr_SR0376_Afinitor_SEGA.pdf cdr_compelte_SR0376_Afinitor_Apr-17-15.pdf SR0376 Afinitor SEGA_Template_PI_Submissions.pdf SR0376_AfinitorSEGA_CL_Report_e.pdf SR0376_AfinitorSEGA_PE_Report.pdf	Mar 19, 2014	Reimbursement Review	Complete	SR0376-000
Icatibant	cdr_SR0375_Firazyr.pdf cdr_complete_SR0375_Firazyr_Dec-23-14.pdf SR0375_Firazyr_CL_Report.pdf SR0375_Firazyr_PE_Report.pdf	Mar 4, 2014	Reimbursement Review	Complete	SR0375-000
Ranibizumab	cdr_SR0373_Lucentis.pdf cdr_complete_SR0373_Lucentis_CNV_Feb-20-15.pdf SR0373_LucentisCNV_CL_Report_e.pdf SR0373_LucentisCNV_PE_Report_e.pdf SR0373_Lucentis_PI_Submissions_e.pdf	Feb 28, 2014	Reimbursement Review	Complete	SR0373-000
Pasireotide diaspartate	cdr_SR0372_Signifor.pdf cdr_complete_SR0372_Signifor_Feb-26-15.pdf SR0372_Signifor_CL_Report.pdf SR0372_Signifor_PE_Report.pdf SR0372 Signifor_PI_Submissions.pdf	Feb 27, 2014	Reimbursement Review	Complete	SR0372-000
Umeclidinium/vilanterol	cdr_SR0371_Anoro_Ellipta.pdf cdr_complete_SR0371_Anoro_Ellipta_Jan-23-15.pdf SR0371_Anoro_Ellipta_PI_Submissions.pdf SR0371_Anoro_Ellipta_CL_Report_e.pdf SR0371_Anoro_Ellipta_PE_Report_e.pdf	Feb 26, 2014	Reimbursement Review	Complete	SR0371-000

Provisional Funding Algorithm

Displaying 76 - 81 of 81